BIO Protocol is a decentralized platform aimed at revolutionizing the funding and commercialization of biotechnology and decentralized science (DeSci). By allowing global participation, it enables patients, scientists, and investors to collaboratively fund, build, and own tokenized biotech projects and intellectual property (IP). This creates new opportunities for funding and accelerates the progress of life science innovations that have traditionally struggled due to complex funding processes, resource gaps, and fragmented IP ownership.

The protocol addresses key challenges in the biotech space, such as lengthy grant application processes and the "Valley of Death," where promising early-stage discoveries fail to reach commercialization. BIO Protocol leverages decentralized funding, capital efficiency, and shared IP ownership to reduce risks and costs, allowing a more inclusive and global approach to scientific advancement. It also provides liquidity to traditionally illiquid biotech assets, helping bridge the gap between innovative research and market-ready solutions.

At the heart of BIO Protocol is the BIO token, which enables governance and gives holders access to exclusive funding rounds and tokenized IP. The token also facilitates the coordination and support of BioDAOs, ensuring that participants can contribute and benefit from the growth of the ecosystem. BIO Protocol is transforming how biotech research is funded, developed, and shared, fostering a more open, efficient, and innovative environment for the entire industry.